{"transactions":[{"id":674204,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2026-08-27T22:37:34.000Z","date":"2026-08-25","kind":"sale","planned":false,"acquired":false,"shares":3350,"price":305.07,"value":1021984.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $304.64 to $305.41, inclusive. The reporting person undertakes to provide UFP Technologies, Inc., any security holder of UFP Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":21112,"source":{"system":"sec-edgar","filing":"0002084956-26-000064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914156/000208495626000064/form4.xml","form_type":"4"}},{"id":674203,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2026-08-27T22:37:34.000Z","date":"2026-08-25","kind":"sale","planned":false,"acquired":false,"shares":3650,"price":303.97,"value":1109490.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $303.58 to $304.49, inclusive. The reporting person undertakes to provide UFP Technologies, Inc., any security holder of UFP Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":24462,"source":{"system":"sec-edgar","filing":"0002084956-26-000064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914156/000208495626000064/form4.xml","form_type":"4"}},{"id":746935,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2026-06-08T16:33:22.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":802,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units issued under the issuer's 2009 Non-Employee Director Stock Incentive Plan that are to be settled solely in shares of Common Stock. The units vest with respect to 100% of the shares on May 31, 2027, so long as the recipient continues as a director of the Issuer through the vesting date."}],"balance_after":28112,"source":{"system":"sec-edgar","filing":"0002084956-26-000035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914156/000208495626000035/form4.xml","form_type":"4"}},{"id":1120368,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2025-06-06T18:47:57.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units issued under the issuer's 2009 Non-Employee Director Stock Incentive Plan that are to be settled solely in shares of Common Stock. The units vest with respect to 100% of the shares on May 31, 2026, so long as the recipient continues as a director of the Issuer through the vesting date."}],"balance_after":27310,"source":{"system":"sec-edgar","filing":"0001062993-25-011131","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914156/000106299325011131/form4.xml","form_type":"4"}},{"id":1168603,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-04-21T16:11:08.000Z","date":"2025-04-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, each option to purchase Shares (each, an \"Option\")  that was outstanding and unexercised as of immediately prior to the Effective Time, which has a per share exercise price that is less than the Offer Price (an \"In the Money Option\"), to the extent unvested, was accelerated and became fully vested and exercisable.  Each outstanding and unexercised vested option (after giving effect to the acceleration treatment set forth in the preceding sentence) at the Effective Time was cancelled and converted into the right to receive a cash payment equal to (i) the excess of (A) the Offer Price over (B) the exercise price payable per Share of such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of March 4, 2025, by and among Chimerix, Inc. (\"Chimerix\"), Jazz Pharmaceuticals Public Limited Company (\"Parent\") and Pinetree Acquisition Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Purchaser\"). Pursuant to the Merger Agreement, Parent and Purchaser launched a tender offer (the \"Offer\") for all outstanding shares of common stock of Chimerix (each, a \"Share\") for an offer price of $8.55 per Share in cash (the \"Offer Price\"), without interest and subject to reduction for any applicable withholding taxes. The Offer expired at the end of the day, one minute after 11:59 p.m. Eastern Time on April 17, 2025. [continues to Footnote 2]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"[continues from Footnote 1] On April 21, 2025, following the filing of the certificate of merger with the Secretary of State of the State of Delaware (the \"Effective Time\"), Purchaser merged with and into Chimerix, with Chimerix continuing as a surviving corporation and an indirect wholly owned subsidiary of Parent (the \"Merger\"). At the Effective Time, each issued and outstanding Share (other than any Excluded Shares (as such term is defined in the Merger Agreement)) was cancelled in exchange for the right to receive the Offer Price, without any interest and subject to any withholding of applicable taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each option to purchase Shares (each, an \"Option\")  that was outstanding and unexercised as of immediately prior to the Effective Time, which has a per share exercise price that is less than the Offer Price (an \"In the Money Option\"), to the extent unvested, was accelerated and became fully vested and exercisable.  Each outstanding and unexercised vested option (after giving effect to the acceleration treatment set forth in the preceding sentence) at the Effective Time was cancelled and converted into the right to receive a cash payment equal to (i) the excess of (A) the Offer Price over (B) the exercise price payable per Share of such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":0.89,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001415889-25-011071","document":"form4-04212025_080404.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000141588925011071/form4-04212025_080404.xml","form_type":"4"}},{"id":1168602,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-04-21T16:11:08.000Z","date":"2025-04-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, each option to purchase Shares (each, an \"Option\")  that was outstanding and unexercised as of immediately prior to the Effective Time, which has a per share exercise price that is less than the Offer Price (an \"In the Money Option\"), to the extent unvested, was accelerated and became fully vested and exercisable.  Each outstanding and unexercised vested option (after giving effect to the acceleration treatment set forth in the preceding sentence) at the Effective Time was cancelled and converted into the right to receive a cash payment equal to (i) the excess of (A) the Offer Price over (B) the exercise price payable per Share of such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of March 4, 2025, by and among Chimerix, Inc. (\"Chimerix\"), Jazz Pharmaceuticals Public Limited Company (\"Parent\") and Pinetree Acquisition Sub, Inc., an indirect wholly owned subsidiary of Parent (\"Purchaser\"). Pursuant to the Merger Agreement, Parent and Purchaser launched a tender offer (the \"Offer\") for all outstanding shares of common stock of Chimerix (each, a \"Share\") for an offer price of $8.55 per Share in cash (the \"Offer Price\"), without interest and subject to reduction for any applicable withholding taxes. The Offer expired at the end of the day, one minute after 11:59 p.m. Eastern Time on April 17, 2025. [continues to Footnote 2]"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"[continues from Footnote 1] On April 21, 2025, following the filing of the certificate of merger with the Secretary of State of the State of Delaware (the \"Effective Time\"), Purchaser merged with and into Chimerix, with Chimerix continuing as a surviving corporation and an indirect wholly owned subsidiary of Parent (the \"Merger\"). At the Effective Time, each issued and outstanding Share (other than any Excluded Shares (as such term is defined in the Merger Agreement)) was cancelled in exchange for the right to receive the Offer Price, without any interest and subject to any withholding of applicable taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each option to purchase Shares (each, an \"Option\")  that was outstanding and unexercised as of immediately prior to the Effective Time, which has a per share exercise price that is less than the Offer Price (an \"In the Money Option\"), to the extent unvested, was accelerated and became fully vested and exercisable.  Each outstanding and unexercised vested option (after giving effect to the acceleration treatment set forth in the preceding sentence) at the Effective Time was cancelled and converted into the right to receive a cash payment equal to (i) the excess of (A) the Offer Price over (B) the exercise price payable per Share of such In the Money Option, multiplied by (ii) the total number of Shares subject to such In the Money Option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":0.99,"expiration_date":"2034-03-19","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-25-011071","document":"form4-04212025_080404.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000141588925011071/form4-04212025_080404.xml","form_type":"4"}},{"id":1392776,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2024-10-03T19:42:15.000Z","date":"2024-09-06","kind":"gift","planned":false,"acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":26685,"source":{"system":"sec-edgar","filing":"0001062993-24-017375","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914156/000106299324017375/form4.xml","form_type":"4"}},{"id":1472359,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-21T11:11:22.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in a series of 12 equal monthly installments from the date of grant; provided, however, that the option shall become fully vested on the date that is the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Company's 2024 annual stockholder meeting."}],"balance_after":60000,"derivative":{"exercise_price":0.89,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001415889-24-017770","document":"form4-06212024_030618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000141588924017770/form4-06212024_030618.xml","form_type":"4"}},{"id":1487567,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T22:07:13.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":493,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":493,"derivative":{"exercise_price":260.92,"exercise_date":"2025-05-31","expiration_date":"2034-06-05","underlying":"Common Stock, $.01 Par Value","underlying_shares":493},"source":{"system":"sec-edgar","filing":"0001062993-24-012212","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914156/000106299324012212/form4.xml","form_type":"4"}},{"id":1487566,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2024-06-07T22:07:13.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units issued under the issuer's 2009 Non-Employee Director Stock Incentive Plan that are to be settled solely in shares of Common Stock. The units vest with respect to 100% of the shares on May 31, 2025, so long as the recipient continues as a director of the Issuer through the vesting date."}],"balance_after":28185,"source":{"system":"sec-edgar","filing":"0001062993-24-012212","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914156/000106299324012212/form4.xml","form_type":"4"}},{"id":1565042,"issuer":{"id":80651,"kind":"organization","name":"CHIMERIX INC","symbol":"CMRX"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-21T16:10:42.000Z","date":"2024-03-20","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares subject to the stock option will vest and become exercisable on March 20, 2025 and the balance of the shares will vest in a series of 24 equal monthly installments thereafter, such that the option will be fully vested on March 20, 2027, subject to Reporting Person's Continuous Service (as defined in the Plan) through each such vesting date and will vest in full upon a Change in Control (as defined in the Plan)."}],"balance_after":100000,"derivative":{"exercise_price":0.99,"expiration_date":"2034-03-19","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-24-008833","document":"form4-03212024_080334.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1117480/000141588924008833/form4-03212024_080334.xml","form_type":"4"}},{"id":1863012,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T23:27:53.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":703,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":703,"derivative":{"exercise_price":167.98,"exercise_date":"2024-05-31","expiration_date":"2033-06-07","underlying":"Common Stock, $.01 Par Value","underlying_shares":703},"source":{"system":"sec-edgar","filing":"0001062993-23-013202","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914156/000106299323013202/form4.xml","form_type":"4"}},{"id":1863011,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2023-06-08T23:27:53.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":298,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units issued under the issuer's 2009 Non-Employee Director Stock Incentive Plan that are to be settled solely in shares of Common Stock. The units vest with respect to 100% of the shares on May 31, 2024, so long as the recipient continues as a director of the Issuer through the vesting date."}],"balance_after":27955,"source":{"system":"sec-edgar","filing":"0001062993-23-013202","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914156/000106299323013202/form4.xml","form_type":"4"}},{"id":1959596,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2023-03-10T20:10:52.000Z","date":"2023-03-10","kind":"gift","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":27657,"source":{"system":"sec-edgar","filing":"0001062993-23-006525","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914156/000106299323006525/form4.xml","form_type":"4"}},{"id":2236755,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T21:18:17.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":1646,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1646,"derivative":{"exercise_price":77.28,"exercise_date":"2023-05-31","expiration_date":"2032-06-08","underlying":"Common Stock, $.01 Par Value","underlying_shares":1646},"source":{"system":"sec-edgar","filing":"0001240679-22-000039","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067922000039/edgar.xml","form_type":"4"}},{"id":2236754,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2022-06-10T21:18:17.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":647,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units issued under the issuer's 2009 Non-Employee Director Stock Incentive Plan that are to be settled solely in shares of Common Stock. The units vest with respect to 100% of the shares on May 31, 2023, so long as the recipient continues as a director of the Issuer through the vesting date."}],"balance_after":28657,"source":{"system":"sec-edgar","filing":"0001240679-22-000039","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067922000039/edgar.xml","form_type":"4"}},{"id":2456936,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-12-29T21:21:05.000Z","date":"2021-12-28","kind":"disposition_to_issuer","acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") that was outstanding and unexercised was cancelled and converted into the right to receive a cash payment equal to (A) the excess, if any, of (x) the Offer Price over (y) the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") that was outstanding and unexercised was cancelled and converted into the right to receive a cash payment equal to (A) the excess, if any, of (x) the Offer Price over (y) the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") that was outstanding and unexercised was cancelled and converted into the right to receive a cash payment equal to (A) the excess, if any, of (x) the Offer Price over (y) the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":30.47,"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001399529-21-000202","document":"wf-form4_164081284688017.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000139952921000202/wf-form4_164081284688017.xml","form_type":"4"}},{"id":2456935,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-12-29T21:21:05.000Z","date":"2021-12-28","kind":"disposition_to_issuer","acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") that was outstanding and unexercised was cancelled and converted into the right to receive a cash payment equal to (A) the excess, if any, of (x) the Offer Price over (y) the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") that was outstanding and unexercised was cancelled and converted into the right to receive a cash payment equal to (A) the excess, if any, of (x) the Offer Price over (y) the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") that was outstanding and unexercised was cancelled and converted into the right to receive a cash payment equal to (A) the excess, if any, of (x) the Offer Price over (y) the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":21.61,"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001399529-21-000202","document":"wf-form4_164081284688017.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000139952921000202/wf-form4_164081284688017.xml","form_type":"4"}},{"id":2456934,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-12-29T21:21:05.000Z","date":"2021-12-28","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") that was outstanding and unexercised was cancelled and converted into the right to receive a cash payment equal to (A) the excess, if any, of (x) the Offer Price over (y) the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") that was outstanding and unexercised was cancelled and converted into the right to receive a cash payment equal to (A) the excess, if any, of (x) the Offer Price over (y) the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") that was outstanding and unexercised was cancelled and converted into the right to receive a cash payment equal to (A) the excess, if any, of (x) the Offer Price over (y) the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":15.44,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001399529-21-000202","document":"wf-form4_164081284688017.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000139952921000202/wf-form4_164081284688017.xml","form_type":"4"}},{"id":2456933,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-12-29T21:21:05.000Z","date":"2021-12-28","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") that was outstanding and unexercised was cancelled and converted into the right to receive a cash payment equal to (A) the excess, if any, of (x) the Offer Price over (y) the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") that was outstanding and unexercised was cancelled and converted into the right to receive a cash payment equal to (A) the excess, if any, of (x) the Offer Price over (y) the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") that was outstanding and unexercised was cancelled and converted into the right to receive a cash payment equal to (A) the excess, if any, of (x) the Offer Price over (y) the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"exercise_price":10.31,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001399529-21-000202","document":"wf-form4_164081284688017.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000139952921000202/wf-form4_164081284688017.xml","form_type":"4"}},{"id":2456932,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-12-29T21:21:05.000Z","date":"2021-12-28","kind":"disposition_to_issuer","acquired":false,"shares":3333,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one Share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each Issuer RSU that was then outstanding was cancelled and converted into the right to receive a cash payment equal to (A) the Offer Price multiplied by (B) the total number of Shares subject to such Issuer RSU immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each Issuer RSU that was then outstanding was cancelled and converted into the right to receive a cash payment equal to (A) the Offer Price multiplied by (B) the total number of Shares subject to such Issuer RSU immediately prior to the Effective Time (without regard to vesting)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"At the Effective Time, each Issuer RSU that was then outstanding was cancelled and converted into the right to receive a cash payment equal to (A) the Offer Price multiplied by (B) the total number of Shares subject to such Issuer RSU immediately prior to the Effective Time (without regard to vesting)."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001399529-21-000202","document":"wf-form4_164081284688017.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000139952921000202/wf-form4_164081284688017.xml","form_type":"4"}},{"id":2456931,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-29T21:21:05.000Z","date":"2021-12-28","kind":"disposition_to_issuer","acquired":false,"shares":5000,"price":38.25,"value":191250.0,"ownership":{"direct":false,"nature":"By Marc D. Kozin Revocable Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 17, 2021, by and among the Issuer, Novo Nordisk A/S, a Danish aktieselskab (\"Novo\"), and NNUS New Research, Inc., a Delaware corporation and a wholly owned indirect subsidiary of Novo (\"Purchaser\"), to which Purchaser completed a tender offer for shares of common stock of Issuer, $0.0001 par value per share (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of December 28, 2021 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share, including the Reporting Person's Shares, was converted into the right to receive $38.25 per Share, in cash, without interest (the \"Offer Price\") and subject to any withholding of taxes, upon the terms and conditions of the Merger Agreement. From and after the Effective Time, all Shares were no longer outstanding and were automatically cancelled."},{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 17, 2021, by and among the Issuer, Novo Nordisk A/S, a Danish aktieselskab (\"Novo\"), and NNUS New Research, Inc., a Delaware corporation and a wholly owned indirect subsidiary of Novo (\"Purchaser\"), to which Purchaser completed a tender offer for shares of common stock of Issuer, $0.0001 par value per share (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of December 28, 2021 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share, including the Reporting Person's Shares, was converted into the right to receive $38.25 per Share, in cash, without interest (the \"Offer Price\") and subject to any withholding of taxes, upon the terms and conditions of the Merger Agreement. From and after the Effective Time, all Shares were no longer outstanding and were automatically cancelled."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 17, 2021, by and among the Issuer, Novo Nordisk A/S, a Danish aktieselskab (\"Novo\"), and NNUS New Research, Inc., a Delaware corporation and a wholly owned indirect subsidiary of Novo (\"Purchaser\"), to which Purchaser completed a tender offer for shares of common stock of Issuer, $0.0001 par value per share (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of December 28, 2021 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share, including the Reporting Person's Shares, was converted into the right to receive $38.25 per Share, in cash, without interest (the \"Offer Price\") and subject to any withholding of taxes, upon the terms and conditions of the Merger Agreement. From and after the Effective Time, all Shares were no longer outstanding and were automatically cancelled."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001399529-21-000202","document":"wf-form4_164081284688017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000139952921000202/wf-form4_164081284688017.xml","form_type":"4"}},{"id":2456930,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-29T21:21:05.000Z","date":"2021-12-28","kind":"disposition_to_issuer","acquired":false,"shares":6333,"price":38.25,"value":242237.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 17, 2021, by and among the Issuer, Novo Nordisk A/S, a Danish aktieselskab (\"Novo\"), and NNUS New Research, Inc., a Delaware corporation and a wholly owned indirect subsidiary of Novo (\"Purchaser\"), to which Purchaser completed a tender offer for shares of common stock of Issuer, $0.0001 par value per share (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of December 28, 2021 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share, including the Reporting Person's Shares, was converted into the right to receive $38.25 per Share, in cash, without interest (the \"Offer Price\") and subject to any withholding of taxes, upon the terms and conditions of the Merger Agreement. From and after the Effective Time, all Shares were no longer outstanding and were automatically cancelled."},{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 17, 2021, by and among the Issuer, Novo Nordisk A/S, a Danish aktieselskab (\"Novo\"), and NNUS New Research, Inc., a Delaware corporation and a wholly owned indirect subsidiary of Novo (\"Purchaser\"), to which Purchaser completed a tender offer for shares of common stock of Issuer, $0.0001 par value per share (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of December 28, 2021 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share, including the Reporting Person's Shares, was converted into the right to receive $38.25 per Share, in cash, without interest (the \"Offer Price\") and subject to any withholding of taxes, upon the terms and conditions of the Merger Agreement. From and after the Effective Time, all Shares were no longer outstanding and were automatically cancelled."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of November 17, 2021, by and among the Issuer, Novo Nordisk A/S, a Danish aktieselskab (\"Novo\"), and NNUS New Research, Inc., a Delaware corporation and a wholly owned indirect subsidiary of Novo (\"Purchaser\"), to which Purchaser completed a tender offer for shares of common stock of Issuer, $0.0001 par value per share (each, a \"Share\") and thereafter merged with and into the Issuer (the \"Merger\") effective as of December 28, 2021 (the \"Effective Time\"). At the Effective Time, each issued and outstanding Share, including the Reporting Person's Shares, was converted into the right to receive $38.25 per Share, in cash, without interest (the \"Offer Price\") and subject to any withholding of taxes, upon the terms and conditions of the Merger Agreement. From and after the Effective Time, all Shares were no longer outstanding and were automatically cancelled."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001399529-21-000202","document":"wf-form4_164081284688017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000139952921000202/wf-form4_164081284688017.xml","form_type":"4"}},{"id":2573068,"issuer":{"id":135573,"kind":"organization","name":"Isleworth Healthcare Acquisition Corp.","symbol":"ISLE"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-10T21:20:10.000Z","date":"2021-09-08","kind":"other","acquired":false,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"In connection with the resignation of the reporting person from the Issuer's board of directors, the reporting person transferred for no consideration 36,000 shares of Issuer common stock to the new director of the Issuer filling the vacancy left by the reporting person's resignation."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the resignation of the reporting person from the Issuer's board of directors, the reporting person transferred for no consideration 36,000 shares of Issuer common stock to the new director of the Issuer filling the vacancy left by the reporting person's resignation."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-035571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000089924321035571/doc4.xml","form_type":"4"}},{"id":2608312,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-10T22:44:44.000Z","date":"2021-08-10","kind":"purchase","acquired":true,"shares":3000,"price":23.662,"value":70986.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $23.455 to $23.840, inclusive. The Reporting Person undertakes to provide to Dicerna Pharmaceuticals, Inc., any security holder of Dicerna Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":6333,"source":{"system":"sec-edgar","filing":"0001399529-21-000144","document":"wf-form4_162863546792743.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000139952921000144/wf-form4_162863546792743.xml","form_type":"4"}},{"id":2672813,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-11T16:50:05.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":1786,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1786,"derivative":{"exercise_price":57.34,"exercise_date":"2022-05-31","expiration_date":"2031-06-09","underlying":"Common Stock, $.01 Par Value","underlying_shares":1786},"source":{"system":"sec-edgar","filing":"0001240679-21-000044","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067921000044/edgar.xml","form_type":"4"}},{"id":2672812,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2021-06-11T16:50:05.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units issued under the issuer's 2009 Non-Employee Director Stock Incentive Plan that are to be settled solely in shares of Common Stock. The units vest with respect to 100% of the shares on May 31, 2022, so long as the recipient continues as a director of the Issuer through the vesting date."}],"balance_after":28010,"source":{"system":"sec-edgar","filing":"0001240679-21-000044","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067921000044/edgar.xml","form_type":"4"}},{"id":2679053,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-06-08T01:35:07.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the option will vest in full on the next regularly scheduled annual meeting of the stockholders of the Issuer that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer as a director through each such date or, if earlier, such annual meeting."}],"balance_after":15000,"derivative":{"exercise_price":30.47,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001399529-21-000109","document":"wf-form4_162311608345843.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000139952921000109/wf-form4_162311608345843.xml","form_type":"4"}},{"id":2679052,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-08T01:35:07.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents RSUs that shall vest and become nonforfeitable with respect to one-hundred percent (100%) of the total number of RSUs on the earlier of (i) 12 months from June 3, 2021 (\"Grant Date\") and (ii) the next regularly scheduled annual meeting of stockholders of the Issuer that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer as a director through such date or, if earlier, such annual meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents RSUs that shall vest and become nonforfeitable with respect to one-hundred percent (100%) of the total number of RSUs on the earlier of (i) 12 months from June 3, 2021 (\"Grant Date\") and (ii) the next regularly scheduled annual meeting of stockholders of the Issuer that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer as a director through such date or, if earlier, such annual meeting."}],"balance_after":3333,"derivative":{"underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001399529-21-000109","document":"wf-form4_162311608345843.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000139952921000109/wf-form4_162311608345843.xml","form_type":"4"}},{"id":2679051,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-08T01:35:07.000Z","date":"2021-06-03","kind":"exercise","acquired":false,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents RSUs that vested and became nonforfeitable with respect to one-hundred percent (100%) of the total number of RSUs on June 3, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents RSUs that vested and became nonforfeitable with respect to one-hundred percent (100%) of the total number of RSUs on June 3, 2021."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001399529-21-000109","document":"wf-form4_162311608345843.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000139952921000109/wf-form4_162311608345843.xml","form_type":"4"}},{"id":2679050,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-08T01:35:07.000Z","date":"2021-06-03","kind":"exercise","acquired":true,"shares":3333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":3333,"source":{"system":"sec-edgar","filing":"0001399529-21-000109","document":"wf-form4_162311608345843.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000139952921000109/wf-form4_162311608345843.xml","form_type":"4"}},{"id":2797951,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2021-03-10T17:29:00.000Z","date":"2021-03-08","kind":"gift","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":27400,"source":{"system":"sec-edgar","filing":"0001240679-21-000022","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067921000022/edgar.xml","form_type":"4"}},{"id":2797950,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2021-03-10T17:29:00.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":600,"price":54.97,"value":32982.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.91 to $55.10, inclusive. The reporting person undertakes to provide to UFP Technologies, Inc., any security holder of UFP Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":31400,"source":{"system":"sec-edgar","filing":"0001240679-21-000022","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067921000022/edgar.xml","form_type":"4"}},{"id":2797949,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2021-03-10T17:29:00.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":8466,"price":54.35,"value":460127.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.90 to $54.90, inclusive. The reporting person undertakes to provide to UFP Technologies, Inc., any security holder of UFP Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":32000,"source":{"system":"sec-edgar","filing":"0001240679-21-000022","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067921000022/edgar.xml","form_type":"4"}},{"id":2797948,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2021-03-10T17:29:00.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":200,"price":52.59,"value":10518.0,"ownership":{"direct":true},"balance_after":40466,"source":{"system":"sec-edgar","filing":"0001240679-21-000022","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067921000022/edgar.xml","form_type":"4"}},{"id":2797947,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2021-03-10T17:29:00.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":234,"price":51.28,"value":11999.52,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.28 to $51.32, inclusive. The reporting person undertakes to provide to UFP Technologies, Inc., any security holder of UFP Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":40666,"source":{"system":"sec-edgar","filing":"0001240679-21-000022","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067921000022/edgar.xml","form_type":"4"}},{"id":2797946,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2021-03-10T17:29:00.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":500,"price":50.66,"value":25330.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.19 to $51.01, inclusive. The reporting person undertakes to provide to UFP Technologies, Inc., any security holder of UFP Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":40900,"source":{"system":"sec-edgar","filing":"0001240679-21-000022","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067921000022/edgar.xml","form_type":"4"}},{"id":3108690,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2020-06-17T00:00:38.000Z","date":"2020-06-15","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the option vests in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting."}],"balance_after":15000,"derivative":{"exercise_price":21.61,"expiration_date":"2030-06-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-20-016725","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000089924320016725/doc4.xml","form_type":"4"}},{"id":3108689,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-17T00:00:38.000Z","date":"2020-06-15","kind":"grant","acquired":true,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest 12 months from June 15, 2020 (\"Grant Date\"), provided that these RSUs vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through such vesting date or, if earlier, such annual meeting. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest 12 months from June 15, 2020 (\"Grant Date\"), provided that these RSUs vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through such vesting date or, if earlier, such annual meeting. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents restricted stock units (\"RSUs\") that vest 12 months from June 15, 2020 (\"Grant Date\"), provided that these RSUs vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through such vesting date or, if earlier, such annual meeting. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":3333,"derivative":{"underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0000899243-20-016725","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000089924320016725/doc4.xml","form_type":"4"}},{"id":3112399,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-12T20:43:12.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":2482,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2482,"derivative":{"exercise_price":43.95,"exercise_date":"2021-05-31","expiration_date":"2030-06-10","underlying":"Common Stock, $.01 Par Value","underlying_shares":2482},"source":{"system":"sec-edgar","filing":"0001240679-20-000057","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067920000057/edgar.xml","form_type":"4"}},{"id":3112398,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-06-12T20:43:12.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units issued under the issuer's 2009 Non-Employee Director Stock Incentive Plan that are to be settled solely in shares of Common Stock.  The units vest with respect to 100% of the shares on May 31, 2021, so long as the recipient continues as a director of the Issuer through the vesting date."}],"balance_after":41400,"source":{"system":"sec-edgar","filing":"0001240679-20-000057","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067920000057/edgar.xml","form_type":"4"}},{"id":3216484,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-03-11T15:08:41.000Z","date":"2020-03-10","kind":"sale","acquired":false,"shares":1000,"price":47.47,"value":47470.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.10 to $47.84, inclusive. The reporting person undertakes to provide to UFP Technologies, Inc., any security holder of UFP Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":40604,"source":{"system":"sec-edgar","filing":"0001240679-20-000044","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067920000044/edgar.xml","form_type":"4"}},{"id":3216483,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-03-11T15:08:41.000Z","date":"2020-03-10","kind":"sale","acquired":false,"shares":1133,"price":46.21,"value":52355.93,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.03 to $46.50, inclusive. The reporting person undertakes to provide to UFP Technologies, Inc., any security holder of UFP Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":41604,"source":{"system":"sec-edgar","filing":"0001240679-20-000044","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067920000044/edgar.xml","form_type":"4"}},{"id":3216482,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-03-11T15:08:41.000Z","date":"2020-03-10","kind":"sale","acquired":false,"shares":2600,"price":45.55,"value":118430.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.14 to $45.85, inclusive. The reporting person undertakes to provide to UFP Technologies, Inc., any security holder of UFP Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":42737,"source":{"system":"sec-edgar","filing":"0001240679-20-000044","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067920000044/edgar.xml","form_type":"4"}},{"id":3216481,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-03-11T15:08:41.000Z","date":"2020-03-10","kind":"sale","acquired":false,"shares":200,"price":44.84,"value":8968.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.74 to $44.91, inclusive. The reporting person undertakes to provide to UFP Technologies, Inc., any security holder of UFP Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":45337,"source":{"system":"sec-edgar","filing":"0001240679-20-000044","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067920000044/edgar.xml","form_type":"4"}},{"id":3218897,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-10T13:24:09.000Z","date":"2020-03-06","kind":"exercise","acquired":false,"shares":1724,"price":0,"value":0.0,"ownership":{"direct":true},"derivative":{"exercise_price":31.2,"exercise_date":"2018-06-06","expiration_date":"2028-06-06","underlying":"Common Stock, $.01 Par Value","underlying_shares":1724},"source":{"system":"sec-edgar","filing":"0001240679-20-000042","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067920000042/edgar.xml","form_type":"4"}},{"id":3218896,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-10T13:24:09.000Z","date":"2020-03-06","kind":"exercise","acquired":false,"shares":2056,"price":0,"value":0.0,"ownership":{"direct":true},"derivative":{"exercise_price":27.05,"exercise_date":"2017-06-06","expiration_date":"2027-06-06","underlying":"Common Stock, $.01 Par Value","underlying_shares":2056},"source":{"system":"sec-edgar","filing":"0001240679-20-000042","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067920000042/edgar.xml","form_type":"4"}},{"id":3218895,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-10T13:24:09.000Z","date":"2020-03-06","kind":"exercise","acquired":false,"shares":2864,"price":0,"value":0.0,"ownership":{"direct":true},"derivative":{"exercise_price":22.02,"exercise_date":"2016-06-09","expiration_date":"2026-06-09","underlying":"Common Stock, $.01 Par Value","underlying_shares":2864},"source":{"system":"sec-edgar","filing":"0001240679-20-000042","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067920000042/edgar.xml","form_type":"4"}},{"id":3218894,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-10T13:24:09.000Z","date":"2020-03-06","kind":"exercise","acquired":false,"shares":2921,"price":0,"value":0.0,"ownership":{"direct":true},"derivative":{"exercise_price":19.97,"exercise_date":"2015-06-10","expiration_date":"2025-06-10","underlying":"Common Stock, $.01 Par Value","underlying_shares":2921},"source":{"system":"sec-edgar","filing":"0001240679-20-000042","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067920000042/edgar.xml","form_type":"4"}},{"id":3218893,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-10T13:24:09.000Z","date":"2020-03-06","kind":"exercise","acquired":false,"shares":2088,"price":0,"value":0.0,"ownership":{"direct":true},"derivative":{"exercise_price":25.04,"exercise_date":"2014-06-11","expiration_date":"2024-06-11","underlying":"Common Stock, $.01 Par Value","underlying_shares":2088},"source":{"system":"sec-edgar","filing":"0001240679-20-000042","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067920000042/edgar.xml","form_type":"4"}},{"id":3218892,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-10T13:24:09.000Z","date":"2020-03-06","kind":"exercise","acquired":false,"shares":1227,"price":0,"value":0.0,"ownership":{"direct":true},"derivative":{"exercise_price":19.08,"exercise_date":"2013-06-12","expiration_date":"2023-06-12","underlying":"Common Stock, $.01 Par Value","underlying_shares":1227},"source":{"system":"sec-edgar","filing":"0001240679-20-000042","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067920000042/edgar.xml","form_type":"4"}},{"id":3218891,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Righto toBuy)","published_at":"2020-03-10T13:24:09.000Z","date":"2020-03-06","kind":"exercise","acquired":false,"shares":1295,"price":0,"value":0.0,"ownership":{"direct":true},"derivative":{"exercise_price":16.32,"exercise_date":"2012-06-14","expiration_date":"2022-06-14","underlying":"Common Stock, $.01 Par Value","underlying_shares":1295},"source":{"system":"sec-edgar","filing":"0001240679-20-000042","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067920000042/edgar.xml","form_type":"4"}},{"id":3218890,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-10T13:24:09.000Z","date":"2020-03-06","kind":"exercise","acquired":false,"shares":2058,"price":0,"value":0.0,"ownership":{"direct":true},"derivative":{"exercise_price":16.17,"exercise_date":"2011-06-08","expiration_date":"2021-06-08","underlying":"Common Stock, $.01 Par Value","underlying_shares":2058},"source":{"system":"sec-edgar","filing":"0001240679-20-000042","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067920000042/edgar.xml","form_type":"4"}},{"id":3218889,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-03-10T13:24:09.000Z","date":"2020-03-06","kind":"exercise","acquired":true,"shares":1724,"price":31.2,"value":53788.8,"ownership":{"direct":true},"balance_after":45537,"source":{"system":"sec-edgar","filing":"0001240679-20-000042","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067920000042/edgar.xml","form_type":"4"}},{"id":3218888,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-03-10T13:24:09.000Z","date":"2020-03-06","kind":"exercise","acquired":true,"shares":2056,"price":27.05,"value":55614.8,"ownership":{"direct":true},"balance_after":43813,"source":{"system":"sec-edgar","filing":"0001240679-20-000042","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067920000042/edgar.xml","form_type":"4"}},{"id":3218887,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-03-10T13:24:09.000Z","date":"2020-03-06","kind":"exercise","acquired":true,"shares":2864,"price":22.02,"value":63065.28,"ownership":{"direct":true},"balance_after":41757,"source":{"system":"sec-edgar","filing":"0001240679-20-000042","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067920000042/edgar.xml","form_type":"4"}},{"id":3218886,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-03-10T13:24:09.000Z","date":"2020-03-06","kind":"exercise","acquired":true,"shares":2921,"price":19.97,"value":58332.37,"ownership":{"direct":true},"balance_after":38893,"source":{"system":"sec-edgar","filing":"0001240679-20-000042","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067920000042/edgar.xml","form_type":"4"}},{"id":3218885,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-03-10T13:24:09.000Z","date":"2020-03-06","kind":"exercise","acquired":true,"shares":2088,"price":25.04,"value":52283.52,"ownership":{"direct":true},"balance_after":35972,"source":{"system":"sec-edgar","filing":"0001240679-20-000042","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067920000042/edgar.xml","form_type":"4"}},{"id":3218884,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-03-10T13:24:09.000Z","date":"2020-03-06","kind":"exercise","acquired":true,"shares":1227,"price":19.08,"value":23411.16,"ownership":{"direct":true},"balance_after":33884,"source":{"system":"sec-edgar","filing":"0001240679-20-000042","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067920000042/edgar.xml","form_type":"4"}},{"id":3218883,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-03-10T13:24:09.000Z","date":"2020-03-06","kind":"exercise","acquired":true,"shares":1295,"price":16.32,"value":21134.4,"ownership":{"direct":true},"balance_after":32657,"source":{"system":"sec-edgar","filing":"0001240679-20-000042","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067920000042/edgar.xml","form_type":"4"}},{"id":3218882,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-03-10T13:24:09.000Z","date":"2020-03-06","kind":"exercise","acquired":true,"shares":2058,"price":16.17,"value":33277.86,"ownership":{"direct":true},"balance_after":31362,"source":{"system":"sec-edgar","filing":"0001240679-20-000042","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914156/000124067920000042/edgar.xml","form_type":"4"}},{"id":3416667,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-09-12T19:37:21.000Z","date":"2019-09-11","kind":"sale","acquired":false,"shares":455,"price":40.05,"value":18222.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.00 to $40.44, inclusive. The reporting person undertakes to provide to UFP Technologies, Inc., any security holder of UFP Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":29304,"source":{"system":"sec-edgar","filing":"0001373894-19-000067","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914156/000137389419000067/edgar.xml","form_type":"4"}},{"id":3416666,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-09-12T19:37:21.000Z","date":"2019-09-11","kind":"sale","acquired":false,"shares":3342,"price":39.9,"value":133345.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.42 to $39.99, inclusive. The reporting person undertakes to provide to UFP Technologies, Inc., any security holder of UFP Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":29759,"source":{"system":"sec-edgar","filing":"0001373894-19-000067","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914156/000137389419000067/edgar.xml","form_type":"4"}},{"id":3416665,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-09-12T19:37:21.000Z","date":"2019-09-10","kind":"sale","acquired":false,"shares":1075,"price":40.53,"value":43569.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.14 to $40.70, inclusive. The reporting person undertakes to provide to UFP Technologies, Inc., any security holder of UFP Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":33101,"source":{"system":"sec-edgar","filing":"0001373894-19-000067","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914156/000137389419000067/edgar.xml","form_type":"4"}},{"id":3416664,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-09-12T19:37:21.000Z","date":"2019-09-10","kind":"sale","acquired":false,"shares":1535,"price":39.5,"value":60632.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.37 to $39.86, inclusive. The reporting person undertakes to provide to UFP Technologies, Inc., any security holder of UFP Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":34176,"source":{"system":"sec-edgar","filing":"0001373894-19-000067","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914156/000137389419000067/edgar.xml","form_type":"4"}},{"id":3419820,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2019-09-09T15:08:09.000Z","date":"2019-09-05","kind":"exercise","acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":9.25,"exercise_date":"2010-07-01","expiration_date":"2020-07-01","underlying":"Common Stock, $.01 Par Value","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001373894-19-000065","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914156/000137389419000065/edgar.xml","form_type":"4"}},{"id":3419819,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-09T15:08:09.000Z","date":"2019-09-05","kind":"exercise","acquired":false,"shares":2907,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":9.09,"exercise_date":"2010-06-09","expiration_date":"2020-06-09","underlying":"Common Stock, $.01 Par Value","underlying_shares":2907},"source":{"system":"sec-edgar","filing":"0001373894-19-000065","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914156/000137389419000065/edgar.xml","form_type":"4"}},{"id":3419818,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-09-09T15:08:09.000Z","date":"2019-09-05","kind":"exercise","acquired":true,"shares":3500,"price":9.25,"value":32375.0,"ownership":{"direct":true},"balance_after":35711,"source":{"system":"sec-edgar","filing":"0001373894-19-000065","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914156/000137389419000065/edgar.xml","form_type":"4"}},{"id":3419817,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-09-09T15:08:09.000Z","date":"2019-09-05","kind":"exercise","acquired":true,"shares":2907,"price":9.09,"value":26424.63,"ownership":{"direct":true},"balance_after":32211,"source":{"system":"sec-edgar","filing":"0001373894-19-000065","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914156/000137389419000065/edgar.xml","form_type":"4"}},{"id":3481122,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2019-06-22T00:03:15.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests monthly over 12 months from June 20, 2019 (\"Grant Date\") in substantially equal monthly installments, provided that the option will vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each such date or, if earlier, such annual meeting."}],"balance_after":25000,"derivative":{"exercise_price":15.44,"expiration_date":"2029-06-20","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-19-017866","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000089924319017866/doc4.xml","form_type":"4"}},{"id":3497863,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-07T20:32:47.000Z","date":"2019-06-05","kind":"grant","acquired":true,"shares":2756,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2756,"derivative":{"exercise_price":38.61,"exercise_date":"2020-05-31","expiration_date":"2029-06-05","underlying":"Common Stock, $.01 Par Value","underlying_shares":2756},"source":{"system":"sec-edgar","filing":"0001373894-19-000054","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914156/000137389419000054/edgar.xml","form_type":"4"}},{"id":3497862,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-06-07T20:32:47.000Z","date":"2019-06-05","kind":"grant","acquired":true,"shares":907,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units issued under the issuer's 2009 Non-Employee Director Stock Incentive Plan that are to be settled solely in shares of Common Stock.  The units vest with respect to 100% of the shares on May 31, 2020, so long as the recipient continues as a director of the Issuer through the vesting date."}],"balance_after":29304,"source":{"system":"sec-edgar","filing":"0001373894-19-000054","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914156/000137389419000054/edgar.xml","form_type":"4"}},{"id":3686590,"issuer":{"id":131951,"kind":"organization","name":"Dicerna Pharmaceuticals Inc","symbol":"DRNA"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2019-01-26T02:10:33.000Z","date":"2019-01-23","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to one-third of the underlying shares on the one year anniversary of the date of grant and as to the remaining two-thirds of the shares in quarterly installments over the two-year period thereafter, subject in each case to the Reporting Person's continued service through the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":10.31,"expiration_date":"2029-01-23","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-19-001994","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000089924319001994/doc4.xml","form_type":"4"}},{"id":3721106,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-12-21T17:48:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":19500,"price":13.19,"value":257205.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This Company stock option was scheduled to vest 100% on the business day prior to the Company's annual stockholder meeting following May 3, 2018. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This Company stock option was scheduled to vest 100% on the business day prior to the Company's annual stockholder meeting following May 3, 2018. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":10.81,"expiration_date":"2028-05-03","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001104659-18-074341","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000110465918074341/a4.xml","form_type":"4"}},{"id":3721105,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-12-21T17:48:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":19500,"price":21.73,"value":423735.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":2.27,"expiration_date":"2027-05-04","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001104659-18-074341","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000110465918074341/a4.xml","form_type":"4"}},{"id":3721104,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-12-21T17:48:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":13500,"price":20.65,"value":278775.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":3.35,"expiration_date":"2026-05-05","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001104659-18-074341","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000110465918074341/a4.xml","form_type":"4"}},{"id":3721103,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-12-21T17:48:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":13500,"price":17.98,"value":242730.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":6.02,"expiration_date":"2025-05-14","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001104659-18-074341","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000110465918074341/a4.xml","form_type":"4"}},{"id":3721102,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-12-21T17:48:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":14000,"price":17.31,"value":242340.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":6.69,"expiration_date":"2024-05-15","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001104659-18-074341","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000110465918074341/a4.xml","form_type":"4"}},{"id":3721101,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-12-21T17:48:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":14000,"price":11.06,"value":154840.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":12.94,"expiration_date":"2023-06-19","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001104659-18-074341","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000110465918074341/a4.xml","form_type":"4"}},{"id":3721100,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-12-21T17:48:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":20000,"price":16.29,"value":325800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":7.71,"expiration_date":"2022-07-25","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-18-074341","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000110465918074341/a4.xml","form_type":"4"}},{"id":3721099,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-21T17:48:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":3300,"price":24,"value":79200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This restricted stock unit (\"RSU\") award provided for vesting and settlement 100% on the business day prior to the Company's annual stockholder meeting following May 3, 2018 in the form of one share of Company common stock for each RSU. Pursuant to the Merger Agreement, at the Effective Time, each RSU outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to $24.00, multiplied by the number of shares of Company common stock subject to such RSU, less any applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-18-074341","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000110465918074341/a4.xml","form_type":"4"}},{"id":3721098,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-21T17:48:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":7800,"price":24,"value":187200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 17, 2018 (the \"Merger Agreement\"), by and among Endocyte, Inc. (the \"Company\"), Novartis AG (\"Novartis\") and Edinburgh Merger Corporation, a wholly owned subsidiary of Novartis (\"Merger Sub\"), at the effective time (the \"Effective Time\") of the merger of Merger Sub with and into the Company, which Effective Time occurred on December 21, 2018, each share of Company common stock was converted into the right to receive an amount in cash equal to $24.00, without interest and less any applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-18-074341","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000110465918074341/a4.xml","form_type":"4"}},{"id":3735297,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-12T00:42:08.000Z","date":"2018-12-07","kind":"grant","acquired":true,"shares":831,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $5,000 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018."}],"balance_after":7740,"source":{"system":"sec-edgar","filing":"0001209191-18-062119","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000120919118062119/doc4.xml","form_type":"4"}},{"id":3800898,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-02T22:03:53.000Z","date":"2018-09-28","kind":"grant","acquired":true,"shares":16014,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $11,687.50 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $11,687.50 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."}],"balance_after":103647,"source":{"system":"sec-edgar","filing":"0001179110-18-011956","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000117911018011956/edgar.xml","form_type":"4"}},{"id":3860741,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-07-26T20:04:06.000Z","date":"2018-07-25","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in 12 successive equal monthly installments measured from June 6, 2018."}],"balance_after":10000,"derivative":{"exercise_price":0.82,"expiration_date":"2028-07-25","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001615219-18-000046","document":"wf-form4_153263542891597.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000161521918000046/wf-form4_153263542891597.xml","form_type":"4"}},{"id":3871696,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-07-06T22:34:14.000Z","date":"2018-07-04","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in twelve equal monthly installments at the end of each successive month following July 4, 2018."}],"balance_after":12000,"derivative":{"exercise_price":0.9548,"expiration_date":"2028-07-04","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001179110-18-009536","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000117911018009536/edgar.xml","form_type":"4"}},{"id":3874500,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-03T20:38:31.000Z","date":"2018-06-29","kind":"grant","acquired":true,"shares":12880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $11,687.50 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $11,687.50 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."}],"balance_after":87633,"source":{"system":"sec-edgar","filing":"0001179110-18-009350","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000117911018009350/edgar.xml","form_type":"4"}},{"id":3902463,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-07T20:23:35.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":1724,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1724,"derivative":{"exercise_price":31.2,"exercise_date":"2018-06-06","expiration_date":"2028-06-06","underlying":"Common Stock, $.01 Par Value","underlying_shares":1724},"source":{"system":"sec-edgar","filing":"0001739481-18-000028","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914156/000173948118000028/edgar.xml","form_type":"4"}},{"id":3902462,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2018-06-07T20:23:35.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":561,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issued under the issuer's 2009 Non-Employee Director Stock Incentive Plan"}],"balance_after":28397,"source":{"system":"sec-edgar","filing":"0001739481-18-000028","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914156/000173948118000028/edgar.xml","form_type":"4"}},{"id":3931724,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-16T19:56:58.000Z","date":"2018-05-14","kind":"exercise","acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":10.14,"exercise_date":"2008-07-01","expiration_date":"2018-06-29","underlying":"Common Stock, $.01 Par Value","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001739481-18-000024","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914156/000173948118000024/edgar.xml","form_type":"4"}},{"id":3931723,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-16T19:56:58.000Z","date":"2018-05-14","kind":"exercise","acquired":false,"shares":2615,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":12.37,"exercise_date":"2008-06-04","expiration_date":"2018-06-04","underlying":"Common Stock, $.01 Par Value","underlying_shares":2615},"source":{"system":"sec-edgar","filing":"0001739481-18-000024","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914156/000173948118000024/edgar.xml","form_type":"4"}},{"id":3931722,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2018-05-16T19:56:58.000Z","date":"2018-05-14","kind":"exercise","acquired":true,"shares":4500,"price":10.14,"value":45630.0,"ownership":{"direct":true},"balance_after":27836,"source":{"system":"sec-edgar","filing":"0001739481-18-000024","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914156/000173948118000024/edgar.xml","form_type":"4"}},{"id":3931721,"issuer":{"id":4409,"kind":"organization","name":"UFP TECHNOLOGIES INC"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.01 Par Value","published_at":"2018-05-16T19:56:58.000Z","date":"2018-05-14","kind":"exercise","acquired":true,"shares":2615,"price":12.37,"value":32347.55,"ownership":{"direct":true},"balance_after":23336,"source":{"system":"sec-edgar","filing":"0001739481-18-000024","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914156/000173948118000024/edgar.xml","form_type":"4"}},{"id":3945397,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-04T21:07:42.000Z","date":"2018-05-03","kind":"grant","acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of options vest on the business day prior to the next annual stockholder meeting following the date of grant."}],"balance_after":19500,"derivative":{"exercise_price":10.81,"expiration_date":"2028-05-03","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001179110-18-006322","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000117911018006322/edgar.xml","form_type":"4"}},{"id":3945396,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-04T21:07:42.000Z","date":"2018-05-03","kind":"grant","acquired":true,"shares":3300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that will vest 100% on the business day prior to the next annual stockholder meeting following the date of grant, and will be paid in the form of one share of common stock for each restricted stock unit."}],"balance_after":11100,"source":{"system":"sec-edgar","filing":"0001179110-18-006322","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000117911018006322/edgar.xml","form_type":"4"}},{"id":3972251,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-03T21:26:28.000Z","date":"2018-03-30","kind":"grant","acquired":true,"shares":14411,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $11,687.50 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $11,687.50 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."}],"balance_after":74753,"source":{"system":"sec-edgar","filing":"0001179110-18-005303","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000117911018005303/edgar.xml","form_type":"4"}},{"id":4111010,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-04T01:42:32.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":8348,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $11,687.50 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of $11,687.50 of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."}],"balance_after":60342,"source":{"system":"sec-edgar","filing":"0001179110-18-000450","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000117911018000450/edgar.xml","form_type":"4"}},{"id":4194096,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-03T23:47:40.000Z","date":"2017-09-29","kind":"grant","acquired":true,"shares":8230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."}],"balance_after":51994,"source":{"system":"sec-edgar","filing":"0001179110-17-013053","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000117911017013053/edgar.xml","form_type":"4"}},{"id":4249960,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-07-27T12:51:09.000Z","date":"2017-07-26","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in 12 successive equal monthly installments measured from July 26, 2017."}],"balance_after":12000,"derivative":{"exercise_price":4.08,"expiration_date":"2027-07-26","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001615219-17-000051","document":"wf-form4_150115985633013.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000161521917000051/wf-form4_150115985633013.xml","form_type":"4"}},{"id":4263760,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":19195,"kind":"person","name":"KOZIN MARC D","position":1,"cik":"0001241647","reported_name":"KOZIN MARC D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-05T23:11:52.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":6477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported on this Form 4 were issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director and committee member, pursuant to the Issuer's non-employee director compensation plan."}],"balance_after":43764,"source":{"system":"sec-edgar","filing":"0001179110-17-010099","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241647/000117911017010099/edgar.xml","form_type":"4"}}],"next_cursor":"2017-07-05T23:11:52.000000Z,4263760"}